John Rose, MD
Plastic Surgery · San Francisco, CANPI 1255623567
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $871 of the $1,246 with a category attached, or 69.9%. Medical Microinstruments, Inc. accounts for 69.9% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2024 at $941 and has fallen 96.8% since, to $30 in 2025. That places this record below the midpoint for plastic surgery clinicians in CA, where the typical reported total is $1,972.
Across 12 payments — averaging $103.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Microinstruments, Inc.$871
- TELA Bio, Inc.$126
- Mentor Worldwide LLC$118
- Boston Scientific$61
- Polynovo North America LLC$29
- Integra Lifesciences Corporation$21
- plus $19 from 1 others
What the payments were for
- Travel & lodging$87170%
- Food & beverage$37530%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Microinstruments, Inc. | 4 | $871 |
| TELA Bio, Inc. | 3 | $126 |
| Mentor Worldwide LLC | 1 | $118 |
| Boston Scientific | 1 | $61 |
| Polynovo North America LLC | 1 | $29 |
| Integra Lifesciences Corporation | 1 | $21 |
| RTI Surgical, Inc | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,246 in reported general payments places this provider in the 35th percentile of 780 plastic surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ampicillin-SulbactamAmpicillin Sod/Sulbactam Sod | 13 | $2,126 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in San Francisco
- Anne PeledSan Francisco$570K
- Hani SbitanySan Francisco$510K
- Ziv PeledSan Francisco$169K
- Jonathan KaplanSan Francisco$113K
- Dino ElyassniaSan Francisco$108K
- Khashayar MohebaliSan Francisco$75K
- Walter LinSan Francisco$68K
- Rahm NazeraliPalo Alto$1.5M
- Vipul DevBakersfield$1.1M
- Arash MomeniPalo Alto$836K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.